The role of an anesthesiologist in the pandemic of uncontrolled use of psychotropic drugs

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In the modern world, the number of people using various psychotropic drugs increases every day. The situation that has been described in recent decades associated with the use of narcotic and not criminalized substances in international literature as the OPIOID + (plus) crisis.

According to statistics, over the past few years, officially registered deaths from drug overdose have exceeded 70,000 in the United States. Leading causes were synthetic opioids, psychostimulants, and cocaine. This includes prescription opioids, opiates, benzodiazepines, and antidepressants. All aforementioned drugs are used in combination with each other, with alcohol or psychotropic marijuana.

For humans, biological, social, and psychological factors are cause the initiation of psychoactive drugs.

Due to the lack of a well-functioning medical care system for patients with chronic pain, doctors of all specialties treat pain.

In this article, we consider the current situation with mind-altering drugs and apply the role of the anesthesiologist in reducing the growth rate of the opioid pandemic.

About the authors

Dmitrii A. Svirskii

OOO MDC of pain management & rehabilitation; Northern State Medical University

Email: dsvirskiy@mail.ru
ORCID iD: 0000-0001-5798-9209
SPIN-code: 9740-9109

Cand. Med. Sci., Associate professor

Russian Federation, 82, Severodvinskaya st., Arkhangelsk, 163060; Arkhangelsk

Eduard E. Antipin

OOO MDC of pain management & rehabilitation; Northern State Medical University

Email: vard67@mail.ru
ORCID iD: 0000-0002-2386-9281
SPIN-code: 8850-2071

MD, PhD, DSc

Russian Federation, 82, Severodvinskaya st., Arkhangelsk, 163060; Arkhangelsk

Konstantin V. Paromov

City Clinical Hospital № 1 them. EE Volosevich

Email: kp-82@mail.ru
ORCID iD: 0000-0002-5138-3617
SPIN-code: 9673-1896

MD, PhD

Russian Federation, 1, Suvorova st., Arkhangelsk, 163001

Eduard V. Nedashkovsky

Northern State Medical University

Author for correspondence.
Email: arsgmu@mail.ru
ORCID iD: 0000-0001-8919-8196
SPIN-code: 2228-9911

MD, PhD, DSc

Russian Federation, 51, Troitskiy pr., Arkhangelsk, 163069

References

  1. Merlin MD. COVER ARTICLE: Archaeological Evidence for the Tradition of Psychoactive Plant Use in the Old World. Economic Botany. 2003;57(3):295–323. doi: 10.1663/0013-0001(2003)057[0295:aeftto]2.0.co;2
  2. Papadaki PG, Kritikos SP. The history of the poppy and of opium and their expansion in antiquity in the eastern Mediterranean area. Bulletin on Narcotics. 1967;19(4):5–10.
  3. Sigerist HE. Laudanum in the Works of Paracelsus. Bull Hist Med. 1941;(9):530–544.
  4. Davenport-Hines R. Early History. The Pursuit of Oblivion. London: Weidenfeld & Nicolson; 2004.
  5. Zheng Y. The Social Life of Opium in China, 1483–1999. Modern Asian Studies. 2003;37(1):1–39. doi: 10.1017/s0026749x0300101x
  6. Hodgson B. In the Arms of Morpheus: The Tragic History of Laudanum, Morphine, and Patent Medicines. Buffalo, New York, USA: Firefly Books; 2001.
  7. Courtwright D.T. Forces of habit drugs and the making of the modern world (1 ed.). Cambridge, Mass.: Harvard University Press; 2009.
  8. Mandel J. Mythical Roots of US Drug Policy – Soldier’s Disease and Addicts in the Civil War. Haight St. San Francisco; 1779.
  9. druglibrary.org [Internet]. “Opiate Narcotics”. The Report of the Canadian Government Commission of Inquiry into the Non-Medical Use of Drugs. Canadian Government Commission [cited 2021 May 5]. Available from: https://www.druglibrary.org/schaffer/library/studies/ledain/nonmed4.htm
  10. Martin WR, Fraser HF. A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther. 1961;133:388–399.
  11. Chou R, Cruciani RA, Fiellin DA, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15(4):321–337. doi: 10.1016/j.jpain.2014.01.494
  12. Mounteney J, Giraudon I, Denissov G, Griffiths P. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. Int J Drug Policy. 2015;26(7):626–631. doi: 10.1016/j.drugpo.2015.04.003
  13. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302(2):123. doi: 10.1056/nejm198001103020221
  14. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain. 1986;25(2):171–186. doi: 10.1016/0304-3959(86)90091-6
  15. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–227. doi: 10.2105/AJPH.2007.131714
  16. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6(10):662–672. doi: 10.1016/j.jpain.2005.05.004
  17. Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39(1):6–12. doi: 10.1097/AAP.0000000000000022
  18. Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307(13):1377–1378. doi: 10.1001/jama.2012.419
  19. Cicero TJ, Ellis MS, Harney J. Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States. N Engl J Med. 2015;373(18):1789–1790. doi: 10.1056/NEJMc1505541
  20. Meier B. In Guilty Plea, OxyContin Maker to Pay $600 Million. The New York Times. 2007 May 10.
  21. Harriet R, Girion L, Glover S. You want a description of hell?’ OxyContin’s 12-hour problem. Los Angeles Times. 2016 May 5.
  22. Keefe PR. The Family That Built an Empire of Pain: The Sackler dynasty’s ruthless marketing of painkillers has generated billions of dollars – and millions of addicts. The New Yorker. 2017 October 23.
  23. finance.yahoo.com [Internet]. Balsamo M, Mulvihill G. US officials: OxyContin maker to plead to 3 criminal charges [cited 2021 May 5]. Available from: https://finance.yahoo.com/news/ap-exclusive-oxycontin-maker-plead-134849205.html?guccounter=1
  24. David C. The Opioid Timebomb: The Sackler family and how their painkiller fortune helps bankroll London arts. Evening Standart. 2018 March 20.
  25. Mulvihill G. OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement. USA Today 2019 September 15.
  26. Baldwin GT, Seth P, Noonan RK. Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice. JAMA. 2021;325(12):1151-1152. doi: 10.1001/jama.2021.1169
  27. Brummett CM, Waljee JF, Goesling J, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017;152(6):e170504. doi: 10.1001/jamasurg.2017.0504
  28. Mudumbai SC, Oliva EM, Lewis ET, et al. Time-to-Cessation of Postoperative Opioids: A Population-Level Analysis of the Veterans Affairs Health Care System. Pain Med. 2016;17(9):1732–1743. doi: 10.1093/pm/pnw015
  29. Chan FJ, Schwartz AM, Wong J, et al. Use of Chronic Methadone Before Total Knee Arthroplasty. J Arthroplasty. 2017;32(7):2105–2107. doi: 10.1016/j.arth.2017.02.048
  30. Rapp SE, Ready BL, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain. 1995;61(2):195–201. doi: 10.1016/0304-3959(94)00168-e
  31. Lee D, Armaghani S, Archer KR, et al. Preoperative Opioid Use as a Predictor of Adverse Postoperative Self-Reported Outcomes in Patients Undergoing Spine Surgery. J Bone Joint Surg Am. 2014;96(11):e89. doi: 10.2106/JBJS.M.00865
  32. VanDenKerkhof EG, Hopman WM, Goldstein DH, et al. Impact of perioperative pain intensity, pain qualities, and opioid use on chronic pain after surgery: a prospective cohort study. Reg Anesth Pain Med. 2012;37(1):19–27. doi: 10.1097/AAP.0b013e318237516e
  33. Zywiel MG, Stroh DA, Lee SY, et al. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am. 2011;93(21):1988–1993. doi: 10.2106/JBJS.J.01473
  34. Lee H. Opioid-induced hyperalgesia is a paradox for perioperative physician. Korean J Anesthesiol. 2013;64(1):1–2. doi: 10.4097/kjae.2013.64.1.1
  35. Koepke EJ, Manning EL, Miller TE, et al. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med (Lond). 2018;7:16. doi: 10.1186/s13741-018-0097-4
  36. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479–496. doi: 10.1097/AJP.0b013e31816b2f43
  37. Chia YY, Liu K, Wang JJ, et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46(9):872–877. doi: 10.1007/BF03012978
  38. Bekhit MH. Opioid-induced hyperalgesia and tolerance. Am J Ther. 2010;17(5):498–510. doi: 10.1097/MJT.0b013e3181ed83a0
  39. George S, Johns M. Review of nonopioid multimodal analgesia for surgical and trauma patients. Am J Health Syst Pharm. 2020;77(24):2052–2063. doi: 10.1093/ajhp/zxaa301
  40. Saurabh S, Smith JK, Pedersen M, et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11(2):424–430. doi: 10.1016/j.soard.2014.09.017
  41. Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017;152(7):691–697. doi: 10.1001/jamasurg.2017.0898
  42. De Oliveira GS, Jr., Castro-Alves LJ, Khan JH, McCarthy RJ. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2013;119(1):178–190. doi: 10.1097/ALN.0b013e318297630d
  43. Nielsen RV, Fomsgaard JS, Siegel H, et al. Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial. Pain. 2017;158(3):463–470. doi: 10.1097/j.pain.0000000000000782
  44. Heesen M, Rijs K, Hilber N, et al. Effect of intravenous dexamethasone on postoperative pain after spinal anaesthesia – a systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2019;74(8):1047–1056. doi: 10.1111/anae.14666
  45. Bi Y, Ye Y, Ma J, et al. Effect of perioperative intravenous lidocaine for patients undergoing spine surgery: A meta-analysis and systematic review. Medicine (Baltimore). 2020;99(48):e23332. doi: 10.1097/MD.0000000000023332
  46. Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use – United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265–269. doi: 10.15585/mmwr.mm6610a1
  47. Kumar K, Gulotta LV, Dines JS, et al. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017;45(3):636–641. doi: 10.1177/0363546517693665
  48. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442. doi: 10.1111/j.1526–4637.2005.00072.x
  49. Tighe PJ, Le-Wendling LT, Patel A, et al. Clinically derived early postoperative pain trajectories differ by age, sex, and type of surgery. Pain. 2015;156(4):609–617. doi: 10.1097/01.j.pain.0000460352.07836.0d
  50. Webster LR. Risk Factors for Opioid-Use Disorder and Overdose. Anesth Analg. 2017;125(5):1741–1748. doi: 10.1213/ANE.0000000000002496
  51. Blendon RJ, Benson JM. The Public and the Opioid-Abuse Epidemic. N Engl J Med. 2018;378(5):407–411. doi: 10.1056/NEJMp1714529
  52. Wang J, Chen Z. Neuromodulation for Pain Management. Adv Exp Med Biol. 2019;1101:207–223. doi: 10.1007/978-981-13-2050-7_8
  53. Hong T, Wang H, Li G, et al. Systematic Review and Meta-Analysis of 12 Randomized Controlled Trials Evaluating the Efficacy of Invasive Radiofrequency Treatment for Knee Pain and Function. Biomed Res Int. 2019;2019:9037510. doi: 10.1155/2019/9037510
  54. McMillan S, Dwyer T, Amin NH, Ford E. The Evolution of Cryoneurolysis for the Treatment of Shoulder, Hip, and Knee Pain: Where Are We Now and Where Will We Go? A Systematic Review. Surg Technol Int. 2020;37:361–366.
  55. Cai Q, Liu GQ, Huang LS, et al. Effects of erector spinae plane block on postoperative pain and side-effects in adult patients underwent surgery: A systematic review and meta-analysis of randomized controlled trials. Int J Surg. 2020;80:107–116. doi: 10.1016/j.ijsu.2020.05.038
  56. Baeriswyl M, Zeiter F, Piubellini D, et al. The analgesic efficacy of transverse abdominis plane block versus epidural analgesia: A systematic review with meta-analysis. Medicine (Baltimore). 2018;97(26):e11261. doi: 10.1097/MD.0000000000011261
  57. Lam KHS, Hung CY, Chiang YP, et al. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms. J Pain Res. 2020;13:1957–1968. doi: 10.2147/JPR.S247208
  58. Yang Y, Botton MR, Scott ER, Scott SA. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics. 2017;18(7):673–685. doi: 10.2217/pgs-2017-0033
  59. Aviram J, Pud D, Gershoni T, et al. Medical cannabis treatment for chronic pain: Outcomes and prediction of response. Eur J Pain. 2021;25(2):359–374. doi: 10.1002/ejp.1675
  60. Deer TR, Hunter CW, Mehta P, et al. A Systematic Literature Review of Dorsal Root Ganglion Neurostimulation for the Treatment of Pain. Pain Med. 2020;21(8):1581–1589. doi: 10.1093/pm/pnaa005

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies